Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

347 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Real-World Systematic Analysis of Driver Mutations' Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting.
Terrenato I, Ercolani C, Di Benedetto A, Gallo E, Melucci E, Casini B, Rollo F, Palange A, Visca P, Pescarmona E, Melis E, Gallina F, Sacconi A, Cecere FL, Landi L, Cappuzzo F, Ciliberto G, Buglioni S. Terrenato I, et al. Among authors: visca p. Cancers (Basel). 2022 Jun 16;14(12):2971. doi: 10.3390/cancers14122971. Cancers (Basel). 2022. PMID: 35740637 Free PMC article.
A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer.
Bria E, Milella M, Sperduti I, Alessandrini G, Visca P, Corzani F, Giannarelli D, Cerasoli V, Cuppone F, Cecere FL, Marchetti A, Sacco R, Mucilli F, Malatesta S, Guetti L, Vitale L, Ceribelli A, Rinaldi M, Terzoli E, Cognetti F, Facciolo F. Bria E, et al. Among authors: visca p. Lung Cancer. 2009 Dec;66(3):365-71. doi: 10.1016/j.lungcan.2009.02.024. Epub 2009 Mar 27. Lung Cancer. 2009. PMID: 19327866
Melanoma molecular classes and prognosis in the postgenomic era.
Tremante E, Ginebri A, Lo Monaco E, Frascione P, Di Filippo F, Terrenato I, Benevolo M, Mottolese M, Pescarmona E, Visca P, Natali PG, Giacomini P. Tremante E, et al. Among authors: visca p. Lancet Oncol. 2012 May;13(5):e205-11. doi: 10.1016/S1470-2045(12)70003-7. Lancet Oncol. 2012. PMID: 22554548 Review.
Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma.
Cioce M, Ganci F, Canu V, Sacconi A, Mori F, Canino C, Korita E, Casini B, Alessandrini G, Cambria A, Carosi MA, Blandino R, Panebianco V, Facciolo F, Visca P, Volinia S, Muti P, Strano S, Croce CM, Pass HI, Blandino G. Cioce M, et al. Among authors: visca p. Oncogene. 2014 Nov 13;33(46):5319-31. doi: 10.1038/onc.2013.476. Epub 2013 Nov 18. Oncogene. 2014. PMID: 24240684 Free PMC article.
Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells.
Loria R, Bon G, Perotti V, Gallo E, Bersani I, Baldassari P, Porru M, Leonetti C, Di Carlo S, Visca P, Brizzi MF, Anichini A, Mortarini R, Falcioni R. Loria R, et al. Among authors: visca p. Oncotarget. 2015 Feb 20;6(5):2779-93. doi: 10.18632/oncotarget.2995. Oncotarget. 2015. PMID: 25576923 Free PMC article.
An 18-year delay in the clinical presentation of bronchial carcinoid.
Leuzzi G, Forcella D, Melis E, Visca P, Facciolo F. Leuzzi G, et al. Among authors: visca p. Rev Esp Med Nucl Imagen Mol. 2015 Sep-Oct;34(5):327-8. doi: 10.1016/j.remn.2014.12.008. Epub 2015 Jan 24. Rev Esp Med Nucl Imagen Mol. 2015. PMID: 25630601 No abstract available.
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer.
Sette G, Salvati V, Mottolese M, Visca P, Gallo E, Fecchi K, Pilozzi E, Duranti E, Policicchio E, Tartaglia M, Milella M, De Maria R, Eramo A. Sette G, et al. Among authors: visca p. Cell Death Dis. 2015 Aug 6;6(8):e1850. doi: 10.1038/cddis.2015.217. Cell Death Dis. 2015. PMID: 26247735 Free PMC article.
347 results